Categories

10000 to 4crs in 18 months 1000rs to 50crs 300% returns 75% promoter holdings A 50 bagger A sureshot 5 bagger Analysis Another fraud? Auto ancillaries Bank sector Blind sell Brand plays Broking Bse Nse Buy calls cements Ceramics/tiles Counters I don't like Debt free businesses Delisting candidates demerger bets Disclosure- I own them Domestic consumption plays E-Commerce pick Education Exit at rallies Famous analysts Famous stocks FMCG Footwear future multibaggers Gems andJewellery Hidden gems High conviction ideas High dividend plays High potential small caps High ROE stocks Holding companies Hotel sector How they looted you.. Indian stock market Infrastructure sector Interesting Microcaps IT KPO Landbank plays largecap ideas Less than 5 PE stocks Liquor Logistics Market lessons Market outlook for 2013 and 2014 Market underperformers Meeting with the CEO Metals Monopoly businesses My 5 baggers My Favourite counters My paid stock recommendations My stock picking techniques nse bse tips Oil exploration Operator calls Paints Penny stock outlook penny stock updates Pharma sector Poultry stocks PSU Publicity freaks Real estate Renewable energy plays Safe bets Sell recommendations Share market Live shipping stocks short term call SOTP plays stock tips stock under 10rs Stocks to watch out for Strong bonus candidates Takeover candidates TATA product tea Textiles The 13 bagger The 45 bagger Trading companies Transformers Turnaround bets Tyres Uncertain/Risky business models Unique businesses

Search This Blog(Over 800 companies covered in the blog).

Please note

Note: The artciles are not research reports but assimilation of information available on public domain and it should not be treated as a research report.

Registration status with SEBI: I am not registered with SEBI under the (Research Analyst) regulations 2014 and as per clarifications provided by SEBI: “Any person who makes recommendation or offers an opinion concerning securities or public offers only through public media is not required to obtain registration as research analyst under RA Regulations”

Disclosure: It is safe to assume that I might have the dkiscussed companies in my portfolio and hence my point of view can be biased.Readers should consult registered consultants before making any investments
.

Archives : Old artciles

Thursday, March 29, 2012

Ahlcon Parenterals (India) Ltd:Buy/sell/growth prospects and recommendation,news and results,target and analysis,view and outlook,multibagger

Scripscan:Ahlcon Parenterals (India) Ltd
cmp:420
Code:524448

Story:Delhi-based Ahlcon is a two-decade-old firm engaged in the business of parenterals and manufacturers life-saving intravenous fluids and medical disposals.Ahlcon has an installed capacity of 30 million bottles per annum for large-volume parenterals besides 150 million vials of eye drops and injections – both in transparent and white opaque packs – as small volume parenterals. It has a manufacturing unit at Bhiwadi at Rajasthan. The promoter group, led by Bikramjit Ahluwalia, holds 70.9 per cent stake in the company.German healthcare products major B Braun is acquiring majority stake in public-listed formulations and healthcare consumables firm Ahlcon Parenterals (India) Ltd in a deal valuing the company at Rs 331 crore ($65 million).Braun has come up with an open offer to buy 1.87 million shares comprising 26 per cent stake from the public at Rs 460 a piece. This is 10 per cent premium to the last-traded share price of Ahlcon.As per the share purchase agreement, Braun will acquire shares from the promoters and the public to pick up to 75 per cent stake in the company. If the open offer is not too successful and it manages to garner just about 4 per cent or less stake from the public, it would buy out the entire holding of the promoters.This means the promoters will sell out anywhere between 49 per cent and 70.9 per cent of their holding to Braun as a part of the transaction. Given this, Braun will pay the promoters anywhere between Rs 162 crore and Rs 235 crore. Therefore, in total, Braun could end up paying around Rs 250 crore ($50 million).Ahlcon had revenues of Rs 78.65 crore, with net profit of Rs 5.77 crore for trailing four quarters ended December 31, 2011. In the same period, the firm had EBITDA of Rs 14.46 crore. This means Braun has valued Ahlcon at 23x its trailing EBITDA and over 57x its trailing net profit, as per the estimates.I am really not sure what tempted the German major to go for such a massive premium(ahlcon used to trade at mid 60 levels even same time last year).I congratulate those investors who have been patient in this counter for years and now reaping the mind-boggling gains.To conclude,I would like to caution by penning few of the notable examples which got taken over previously and now are trading at 1/4-1/5 of the acquired levels.Camlin got acquired by kokuyo and open offer came at 110 bucks but it quotes presently in the 30's.AP Paper was taken over by US-based International Paper Holding and they gave an open offer at 544 bucks.The scrip presently trades at mere 180 levels.So who knows history can well get repeated in ahlcon too.

Important Disclaimer&Privacy policy

This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: arunsharemarket@gmail.com Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.
 
x

Subscription to Arunthestocksguru

Enter your email address:

Delivered by FeedBurner